EUVIMEDEUVIMED entdecken
Crossref

Triazole-quinoxaline attenuates epithelial-to-mesenchymal transition by suppressing the Wnt/β-catenin pathway in human colorectal cancer cells

Bada Yoon, Rajaghatta N Suresh, Chakrabhavi Dhananjaya Mohan, Kachigere B Harsha, C S Shivakumara, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Gautam Sethi, Kanchugarakoppal S Rangappa, Kwang Seok Ahn

Archives of Biochemistry and Biophysics · 2025

DOI: 10.1016/j.abb.2025.110476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Bada Yoon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science in Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Wnt Signaling Pathway, Colorectal Neoplasms, Quinoxalines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: King Saud University, National Research Foundation of Korea, Ministry of Science ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Wnt/β-catenin signaling pathway regulates key cellular processes, including proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT). Dysregulation of this pathway has been implicated in various human cancers, including colorectal cancer (CRC), where it plays a critical role in promoting EMT and metastatic progression. In a recent study, triazole derivatives were shown to possess anti-EMT activity in cancer cells. Building on this finding, we synthesized a triazolyl-quinoxaline-based small molecule, SRN-18, and evaluated its impact on EMT in CRC cells. Specifically, we investigated the effect of SRN-18 on the mRNA and protein expression levels of CXCR4 and CXCR7, as well as its influence on the expression of MMP-2, MMP-9, and key EMT-associated proteins. As CXCL12 is a known ligand for both CXCR4 and CXCR7, we also examined the effects of CXCL12 stimulation on cell migration and invasion. Western blot analyses were conducted to determine whether SRN-18 modulates the expression of CXCR4/7, MMP-2/9, and EMT markers in the presence or absence of CXCL12 stimulation. Additionally, our findings revealed that the Wnt/β-catenin signaling pathway is involved in SRN-18-mediated EMT suppression. Since inhibition of the Wnt/β-catenin pathway has been shown to reduce the expression of CXCR4 and CXCR7, SRN-18-mediated suppression of this pathway led to the downregulation of CXCR4- and CXCR7-associated signaling proteins, including NF-κB and JNK. In summary, SRN-18 exerted its anti-EMT effects in colorectal cancer cells by targeting the Wnt/β-catenin signaling axis and its downstream signaling cascades.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionWnt Signaling PathwayColorectal NeoplasmsQuinoxalinesTriazolesHumansReceptors, CXCR4Cell MovementCell Line, TumorReceptors, CXCRbeta CateninChemokine CXCL12Gene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CXCR4CXCR7EMTJNKNF-κBWnt/β-catenin

Substanzen

QuinoxalinesReceptors, CXCR4TriazolesCXCR4 protein, humanACKR3 protein, humanReceptors, CXCRbeta CateninChemokine CXCL12

Autor:innen und Institutionen

  • Department of Science in Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.
  • Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore, 570006, Karnataka, India.
  • Systems Toxicology Group, FEST Division, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, Mahatma Gandhi Marg, Lucknow, 226 001, Uttar Pradesh, India; Academy of Scientific and Innovative Research (AcSIR…
  • Department of Chemistry, School of Engineering, University of Mysore, Mysore, 570006, India.
  • Department of Clinical Nutrition and Dietetics, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, 563101, Karnataka, India.
  • Department of Botany and Microbiology, College of Science, King Saud University, PO Box -2455, Riyadh, 11451, Saudi Arabia.

Förderung

  • King Saud University
  • National Research Foundation of Korea
  • Ministry of Science ICT and Future Planning

Zitieren

APA

Yoon, B., Suresh, R. N., Mohan, C. D., Harsha, K. B., Shivakumara, C. S., Chinnathambi, A., Alharbi, S. A., Sethi, G., Rangappa, K. S., & Ahn, K. S. (2025). Triazole-quinoxaline attenuates epithelial-to-mesenchymal transition by suppressing the Wnt/β-catenin pathway in human colorectal cancer cells. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110476

Vancouver

Yoon B, Suresh RN, Mohan CD, Harsha KB, Shivakumara CS, Chinnathambi A, et al. Triazole-quinoxaline attenuates epithelial-to-mesenchymal transition by suppressing the Wnt/β-catenin pathway in human colorectal cancer cells. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110476

BibTeX
@article{Yoon2025,
  author = {Yoon, Bada and Suresh, Rajaghatta N and Mohan, Chakrabhavi Dhananjaya and Harsha, Kachigere B and Shivakumara, C S and Chinnathambi, Arunachalam and Alharbi, Sulaiman Ali and Sethi, Gautam and Rangappa, Kanchugarakoppal S and Ahn, Kwang Seok},
  title = {Triazole-quinoxaline attenuates epithelial-to-mesenchymal transition by suppressing the Wnt/β-catenin pathway in human colorectal cancer cells},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1016/j.abb.2025.110476}
}
Kostenlos starten →